![]() |
市场调查报告书
商品编码
1324357
到 2030 年手术缝线市场预测:按产品类型、材料、原材料、涂层、用途、最终用户和地区进行的全球分析Surgical Sutures Market Forecasts to 2030 - Global Analysis By Product Type, Material, Raw Material, Coating, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球手术缝线市场规模为 48.8 亿美元,预计在预测期内将以 7.8% 的年复合成长率增长,到 2030 年达到 82.5 亿美元。
手术缝合线是一种医疗设备,用于在手术或受伤后闭合伤口并将身体组织连接在一起。通常使用附有线的针来缝合缝线。使用的缝合线类型取决于伤口的特征和位置。医疗专业人员会考虑线的拉伸强度、材料、可操作性和弹性,以便成功连接组织。
据世界卫生组织(WHO)统计,截至2020年2月,大约有2000万至5000万人遭受非致命伤害,其中一些导致骨折,需要进行踝关节置换术和其他骨手术。我不断收到这种情况。
膝关节关节重建、髋关节置换术、子宫切除术、搭桥手术和整容手术的增加增加了这种设备的使用,以更快地闭合伤口。此外,由于老年人进行关节关节重建和器官移植等外科手术的频率不断增加,对外科缝合线的需求和使用正在迅速增加。因此,世界各地的医疗机构需要更先进的设备。
研究人员正在开发新技术并增加微创手术的数量,以造福患者。微创手术比开放性手术便宜,效果更好,并且需要的住院时间更短。这些因素推动了微创手术的接受并限制了市场的扩张。
新兴国家人口对现代医疗设施的需求迅速增长,推动了手术缝合线市场的发展。尖端工具和技术的快速扩散正在将市场推向新的高度。潜在客户被医疗保健系统用于缝合伤口的先进设备所吸引,随着时间的推移帮助市场产生巨额利润。
缺乏合格的外科医生和手术缝合线的高价格阻碍了市场的扩张。可能对市场扩张产生负面影响的另一个重大风险是假冒手术缝线的出现以及手术缝线审批和商业化的严格规定。
COVID-19 对全球经济产生了负面影响。 2020年,许多市场参与企业注意到了下降。疫情期间,许多国家政府推迟了择期手术,以节省医疗资源以应对 COVID-19 紧急情况。这迫使许多市场参与企业和研究机构推迟与其他慢性病相关的项目。然而,随着近期新型冠状病毒肺炎 (COVID-19) 在英国和印度等国家的传播,推迟手术的趋势预计将进一步加剧并影响这些设备的采用。
预计缝合线细分市场在预测期内将占据最大的市场份额。这是医疗保健行业巨大需求的结果。手术线是许多医疗保健领域首选的伤口缝合方法,因为它们价格实惠且可供公众使用。
由于各种冠状动脉疾病、心律失常患病率的增加增加了搭桥手术的需求以及手术缝合线的使用增加,预计心血管手术领域在预测期内将以最高的年复合成长率增长。最复杂和危险的外科手术涉及心血管系统,因此需要最好、最合适的缝合线。此外,由于心脏病患者数量的增加而导致的心血管手术数量的增加也增加了手术缝合线的市场需求。
由于本地和大型企业的存在、缝合线成本高于其他地区、有利的报销环境、不断扩大的政府倡议和医疗保健系统,北美地区在手术缝合线市场占据主导地位。预计该领域将继续由技术日益复杂。北美地区高销售份额的主要要素是该地区的高所得和技术进步。
预计亚太地区将在预测期内实现最高增长。这是由于人口高龄化导致更有可能接受手术,以及政府增加医疗保健系统支出以解决该领域未满足的需求。亚太地区的主要市场包括中国、印度和日本。印度、新加坡和马来西亚等国家医疗旅游的兴起也是推动该地区市场呈指数级增长的关键要素。
According to Stratistics MRC, the Global Surgical Sutures Market is accounted for $4.88 billion in 2023 and is expected to reach $8.25 billion by 2030 growing at a CAGR of 7.8% during the forecast period. A surgical suture is a piece of medical equipment used to close wound edges after surgery or injury and hold body tissues together. Usually, a needle with a thread attached is used to apply it. The characteristics and location of the wound determine which suture should be used. Medical professionals take into account the thread's tensile strength, material, operator friendliness, and elasticity to hold tissues together successfully.
According to the World Health Organization (WHO), till February 2020, around 20-50 million people suffered from non-fatal injuries, of which some resulted in bone fractures, and have consecutively undergone ankle arthroplasty and other bone surgeries.
The use of this device to close wounds more quickly is increasing due to the rise in knee replacements, hip replacements, hysterectomy, bypass surgeries, and cosmetic surgeries. Additionally, the demand for and use of surgical sutures is being increased by the rapidly growing elderly population as a result of the rising frequency of surgical procedures like joint replacement, angioplasty, and organ transplant among elderly patients. This is causing healthcare facilities all over the world to demand more advanced devices.
Researchers are developing new technologies for patients' benefit, which has increased the number of minimally invasive procedures. These procedures are more affordable than open surgeries, offer better results, and require shorter hospital stays. These elements have boosted the acceptance of minimally invasive procedures, which limits the market's expansion.
The market for surgical sutures has been helped by the developing world's population's rapid demand for modern medical facilities. The rapid adoption of cutting-edge tools and technologies by the populace has propelled the market to new heights. Potential customers have been drawn to the sophisticated equipment that the healthcare system uses to suture wounds, which has helped the market generate sizable profits over time.
The market's expansion is hampered by the scarcity of qualified surgeons and the high price of surgical sutures. Another significant risk that could have a negative effect on the market's expansion is the availability of fake surgical sutures and the strict rules governing the approval and commercialization of surgical sutures.
COVID-19 had an adverse impact on the world economy. In 2020, many significant market participants noticed a decline. During the pandemic, the governments of many nations postponed elective surgeries in order to preserve healthcare resources for the COVID-19 emergency. Along with this, the imposition of lockdown forced a number of market participants and research organizations to delay their projects related to other chronic diseases. However, it is anticipated that the recent spread of the new COVID-19 strain in nations like the U.K., India, and others will further the trend of delaying operations and have an impact on the adoption of these devices.
The sutures segment is predicted to hold the largest market share in the estimated timeframe. This is a result of the enormous demand in the healthcare sector. Due to their affordability and ability to be used by the average person, surgical threads have been the preferred method of wound closure in many healthcare sectors.
Due to the increasing prevalence of various coronary artery diseases, arrhythmias, which increase the need for bypass surgeries, and increased use of surgical sutures, the cardiovascular surgery segment is anticipated to grow at the highest CAGR during the projection period. The most complicated and dangerous surgical procedures involve the cardiovascular system, making the best and most appropriate sutures necessary. Additionally, the increased use of cardiovascular surgeries as a result of an increase in patients with heart disorders increases market demand for surgical sutures.
North American region dominated the surgical suture market, and it is predicted to continue dominating the sector due to the presence of local and major players, the high cost of sutures relative to other regions, the favorable reimbursement environment, the expansion of government initiatives, and the sophistication of the healthcare system. The major drivers of North America's significant revenue share include domestically high income and technological advancements in this region.
During the forecast period, Asia Pacific is anticipated to experience the highest growth. This is due to the aging population that is more likely to undergo surgery, as well as an increase in government spending on the healthcare system to address the unmet needs in this area. Major markets in the Asia Pacific region include China, India, and Japan. Another important factor propelling the market in this region toward exponential growth is the rise of medical tourism in nations like India, Singapore, and Malaysia.
Some of the key players profiled in the Surgical Sutures Market include: Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, CPT Sutures, Deme TECH Corporation, Derma Sciences, Dolphin Sutures, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), Healthium MedTech, Integra Lifesciences, Internacional farmaceutica, Lotus Surgicals, Medtronic Plc , Mellon Medical B.V., Peter Surgical, Smith & Nephew, Stryker Corporation, Surgical Specialties Corporation, Sutcon Sutures, Vital Sutures and Zimmer Biomets.
In July 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) approval for the Vercise™ Neural Navigator 5 Software, which when used as part of the Vercise Genus™ Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson's disease or essential tremor.
In August 2022, CONMED Corporation (announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. The transaction is being financed through the Company's existing credit facility.
In March 2022, B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. With the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.